Evolution of airway and systemic manifestations of COPD in a three year period Source: Annual Congress 2009 - Oxygen, end-of-life and care for chronic respiratory patients Year: 2009
Systemic inflammatory reactions in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006
The effectiveness of plasmaferesis in patients with relapsing and progressing course of pulmonary sarcoidosis (5 years follow-up) Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010
Time course of systemic inflammatory markers during acute exacerbation of COPD Source: Eur Respir J 2007; 30: Suppl. 51, 555s Year: 2007
Evolution of systemic response in patients with pulmonary sarcoidosis of different course of the disease during anti-inflammatory treatment Source: Annual Congress 2009 - Sarcoidosis in review Year: 2009
Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study Source: Annual Congress 2011 - COPD management Year: 2011
Five years follow-up after pulmonary rehabilitation of patients with COPD Source: Annual Congress 2010 - Exercise training: new groups, new methods and outcomes Year: 2010
Community follow-up of COPD patients following admission for exacerbation Source: Eur Respir J 2003; 22: Suppl. 45, 244s Year: 2003
Pulmonary and systemic cellular immune response network in patients with mild-moderate COPD Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017
One year follow-up of patients with idiopathic pulmonary fibrosis treated with immunosuppressive therapy Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases Year: 2007
Evolution of cellular inflammatory pattern in induced sputum in patients with mild-moderate asthma for five years Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011
Differences in systemic immune function contribute to exacerbation susceptibility in COPD patients Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015
Systemic inflammatory response associated with injury of the respiratory muscles in healthy subjects and COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 212s Year: 2002
Acute systemic inflammatory response after peak and constant-work-rate exercise test in hospitalised and stable COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 632s Year: 2004
Corticosteroids significantly improve symptom score in patients with active pulmonary sarcoidosis over a two year follow up Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011
Association of systemic inflammation with clinical recovery in patients with acute exacerbation of COPD Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases Year: 2011
Identifying systemic inflammatory markers in the Melbourne COPD exacerbation cohort Source: Eur Respir J 2005; 26: Suppl. 49, 51s Year: 2005
The course of disease of patients who died from asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 217s Year: 2003
Systemic effects of bronchial colonization in early COPD patients enrolled in the PAC-COPD cohort Source: Eur Respir J 2007; 30: Suppl. 51, 212s Year: 2007
Systemic inflammatory response in relation to disease severity and nutritional depletion in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 31s Year: 2004